Mavroudeas Symeon-Evangelos, Apostolos Anastasios, Spyropoulou Despoina, Matthaiopoulos George, Katsaros Odysseas, Kafkas Nikolaos, Tsiambas Evangelos, Aggeli Konstantina, Tousoulis Dimitrios, Tsioufis Constantinos, Toutouzas Konstantinos
1st Department of Cardiology, "Hippokration" General Hospital, National and Kapodistrian University, Athens, Greece.
Department of Radiation Oncology, Medical School, University of Patras, Patras, Greece.
Maedica (Bucur). 2025 Mar;20(1):99-105. doi: 10.26574/maedica.2025.20.1.99.
Stenosis of the aortic valve is a leading cause of severe cardiovascular lesions. Progressive calcification, rheumatic modifications and also congenital events are the main etiopathogenetic factors. Extended fibrotic changes and aberrant ectopic calcification of the specific aortic valve interstitial cells are the most recognizable histopathological features. In fact, the previously referred cells are transformed from their initial myofibroblast phenotype to an osteoblast-like cell formation mediated by an inflammatory process. Concerning the potentially effective anti-calcification, inhibition strategies, some molecules are under investigation. Among them, vitamins seem to be involved in this process by preventing aortic wall extensive calcification. The purpose of the current review was to explore the involvement of Vitamin K complex in the inhibition mechanisms of the human aortic valve calcification process. A systematic retrospective review of the literature was carried out based on PubMed international medical database. The following keywords were used: vitamin, calcification, cardiovascular, stenosis, aorta. A broad spectrum of seventy (n=70) significant articles - focused on the vitamin K complex structural and functional aspects and its implication in anti-calcification mechanisms - were selected for the current review study. The majority of medical data referred to after 2015 published articles, whereas specific references of great importance and value were also included. Specific vitamin K members play a crucial role by regulating the activity of proteins such as osteocalcin that induces endothelial calcification. Interestingly, vitamin K also modifies the function of the matrix-Gla proteins that are implicated in this process. In fact, vitamin K-related molecular and biochemical mechanisms in the human aortic valve calcification inhibition are crucial and represent an interesting field for research.
主动脉瓣狭窄是严重心血管病变的主要原因。进行性钙化、风湿性改变以及先天性因素是主要的病因学因素。特定主动脉瓣间质细胞的广泛纤维化改变和异常异位钙化是最显著的组织病理学特征。事实上,上述细胞从最初的肌成纤维细胞表型转变为由炎症过程介导的成骨样细胞形成。关于潜在有效的抗钙化抑制策略,一些分子正在研究中。其中,维生素似乎通过预防主动脉壁广泛钙化参与这一过程。本综述的目的是探讨维生素K复合物在人类主动脉瓣钙化过程抑制机制中的作用。基于PubMed国际医学数据库对文献进行了系统的回顾性研究。使用了以下关键词:维生素、钙化、心血管、狭窄、主动脉。本综述研究选择了70篇重要文章,这些文章聚焦于维生素K复合物的结构和功能方面及其在抗钙化机制中的意义。大多数医学数据来自2015年后发表的文章,同时也纳入了具有重要意义和价值的特定参考文献。特定的维生素K成员通过调节诱导内皮钙化的骨钙素等蛋白质的活性发挥关键作用。有趣的是,维生素K还改变了参与这一过程的基质Gla蛋白的功能。事实上,维生素K相关的分子和生化机制在人类主动脉瓣钙化抑制中至关重要,是一个有趣的研究领域。